loratadine
SMILES | CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 |
InChIKey | JCCNYMKQOSZNPW-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 3 |
Hydrogen bond donors | 0 |
Rotatable bonds | 1 |
Molecular weight (Da) | 382.1 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Database connections
Ligand site mutations | H1 |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
H1 | HRH1 | Human | Histamine | A | pKi | 7.43 | 7.43 | 7.43 | Guide to Pharmacology |
H1 | HRH1 | Rat | Histamine | A | pKi | 6.46 | 6.46 | 6.46 | ChEMBL |
H1 | HRH1 | Guinea pig | Histamine | A | pKd | 7.14 | 7.14 | 7.14 | ChEMBL |
H1 | HRH1 | Human | Histamine | A | pKi | 6.38 | 7.0 | 7.7 | ChEMBL |
H1 | HRH1 | Human | Histamine | A | pKd | 6.72 | 6.72 | 6.72 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 6.81 | 6.81 | 6.81 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 8.17 | 8.17 | 8.17 | Drug Central |
H1 | HRH1 | Human | Histamine | A | pKi | 8.16 | 8.16 | 8.16 | Drug Central |
H1 | HRH1 | Guinea pig | Histamine | A | pKd | 8.15 | 8.15 | 8.15 | Drug Central |
H1 | HRH1 | Rat | Histamine | A | pKi | 8.19 | 8.19 | 8.19 | Drug Central |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
M1 | ACM1 | Rat | Acetylcholine (muscarinic) | A | Potency | 4.7 | 5.3 | 5.9 | ChEMBL |
H1 | HRH1 | Human | Histamine | A | pIC50 | 6.54 | 6.65 | 6.77 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pIC50 | 6.61 | 6.61 | 6.61 | ChEMBL |
NPS | NPSR1 | Human | Neuropeptide S | A | Potency | 4.9 | 5.13 | 5.4 | ChEMBL |
TSH | TSHR | Human | Glycoprotein hormone | A | Potency | 4.4 | 4.55 | 4.7 | ChEMBL |